Featured Content

More News

Sector News

More News


News and Analysis

  • Come Join Our Commuity We are offering discounted subscription plans to join BioMedReports.com for a limited time.
  • Q&A with LabStyle Innovations Exec VP, Todd Durniak Recently, LabStyle Innovations Corp. (OTCQB: DRIO), developer of the Dario™ Diabetes Management Solution, announced it had closed a round of funding totaling approximately $2.5 million. According to management, the monies will be used to support the global rollout and initial U.S. commercial launch of their flagship product Dario™ for working capital purposes.
More News

Newsletter

BioMedReports Abeona Announces FDA Allowance of (IND) for Phase 1/2 Clinical Study With ABO-101 Gene Therapy for Sanfilippo: https://t.co/Q4tDIzk0jB $ABEO
20hreplyretweetfavorite
BioMedReports CEL-SCI Announces the Closing of Its $5 Million Registered Direct Offering: https://t.co/qL53OVHEp4 $CVM
20hreplyretweetfavorite
BioMedReports Advanced Accelerator Applications preparing for Lutathera launch by scaling up production in Ivrea, Italy: https://t.co/42akkT1M4M $AAAP

RSS Subscription

BMR:1